Currently out of the existing stock ratings of Farzin Haque, 2 are a BUY (100%).

Farzin Haque

Work Performance Price Targets & Ratings Chart

Analyst Farzin Haque, currently employed at JEFFERIES,

Farzin Haque’s has documented 4 price targets and ratings displayed on 1 stocks.

Most recent stock forecast was given on PYXS, Pyxis Oncology at 18-Mar-2025.

Wall Street Analyst Farzin Haque

Analyst best performing recommendations are on PYXS (PYXIS ONCOLOGY).
PYXS Pyxis Oncology

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 30-Nov-2023

$7

$4.23 (152.71%)

$7

3 months 22 days ago
(24-Mar-2026)

5/11 (45.45%)

$5.64 (414.71%)

187

Buy Since 08-Aug-2024

$8

$5.23 (188.81%)

$7

3 months 22 days ago
(24-Mar-2026)

0/3 (0%)

$6.64 (488.24%)

Buy Since 10-Nov-2023

$5

6 months 27 days ago
(19-Dec-2025)

0/6 (0%)

$3.27 (189.02%)

Buy Since 08-Nov-2024

$8

$5.23 (188.81%)

$13

7 months 22 days ago
(24-Nov-2025)

0/2 (0%)

$2.85 (55.34%)

Buy Since 07-May-2024

$6

$3.23 (116.61%)

$10

1 years 3 months 28 days ago
(18-Mar-2025)

0/2 (0%)

$4.94 (466.04%)

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Farzin Haque?

On 2024

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?